LV10054B - Antiviral or antibacterial compound and method of use - Google Patents

Antiviral or antibacterial compound and method of use Download PDF

Info

Publication number
LV10054B
LV10054B LVP-92-508A LV920508A LV10054B LV 10054 B LV10054 B LV 10054B LV 920508 A LV920508 A LV 920508A LV 10054 B LV10054 B LV 10054B
Authority
LV
Latvia
Prior art keywords
dimer
lysozyme
vas
ribonuclease
treatment
Prior art date
Application number
LVP-92-508A
Other languages
English (en)
Latvian (lv)
Other versions
LV10054A (lv
Inventor
Witold Kiczka
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of LV10054A publication Critical patent/LV10054A/xx
Publication of LV10054B publication Critical patent/LV10054B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LVP-92-508A 1988-05-26 1992-12-28 Antiviral or antibacterial compound and method of use LV10054B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17858888A 1988-05-26 1988-05-26
PCT/US1988/001785 WO1989011294A1 (en) 1988-05-26 1988-05-26 Antiviral or antibacterial compound and method of use
OA59731A OA09785A (en) 1988-05-26 1990-01-26 Antiviral or antibacterial compound and method of use

Publications (2)

Publication Number Publication Date
LV10054A LV10054A (lv) 1994-05-10
LV10054B true LV10054B (en) 1995-02-20

Family

ID=33162813

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-508A LV10054B (en) 1988-05-26 1992-12-28 Antiviral or antibacterial compound and method of use

Country Status (23)

Country Link
US (3) US5200182A (hu)
EP (1) EP0380484B1 (hu)
JP (1) JPH0649659B2 (hu)
AT (1) ATE93143T1 (hu)
AU (1) AU624331B2 (hu)
BG (1) BG60544B1 (hu)
CA (1) CA1335425C (hu)
CS (1) CS277030B6 (hu)
DK (1) DK173078B1 (hu)
ES (1) ES2011577A6 (hu)
FI (1) FI900412A0 (hu)
HK (1) HK42394A (hu)
HU (1) HU204710B (hu)
IL (1) IL90092A (hu)
LV (1) LV10054B (hu)
MA (1) MA21560A1 (hu)
MW (1) MW390A1 (hu)
OA (1) OA09785A (hu)
PH (1) PH26284A (hu)
RU (1) RU2092183C1 (hu)
WO (1) WO1989011294A1 (hu)
YU (1) YU109289A (hu)
ZA (1) ZA893382B (hu)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2092183C1 (ru) * 1988-05-26 1997-10-10 Ника Хелт Продактс Лимитед (Лихтенштейн) Антивирусный или антибактериальный состав и способ его употребления
US5989880A (en) * 1990-01-08 1999-11-23 Nika Health Products Ltd. Method of preparing lysozyme dimers
WO1991010730A1 (en) * 1990-01-08 1991-07-25 Nika Health Products Ltd. Method of preparing ribonuclease dimers
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
CH682541A5 (de) * 1992-06-23 1993-10-15 Urs Viktor Dr Wirth Biochemische Inaktivierung von RNA-Viren.
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
US6716813B2 (en) * 2000-11-28 2004-04-06 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US7338936B2 (en) * 2000-11-28 2008-03-04 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
JP2002187853A (ja) * 2000-12-21 2002-07-05 Shinei Ferumentekku:Kk 動物の乳頭除菌剤および菌環境改善方法
DE10210285A1 (de) * 2002-03-08 2003-11-13 Medigene Ag Reversibles Toxin und seine Verwendung
WO2005115477A2 (en) 2004-04-13 2005-12-08 Quintessence Biosciences, Inc. Non-natural ribonuclease conjugates as cytotoxic agents
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US7348301B2 (en) * 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems
JP2009541333A (ja) * 2006-06-23 2009-11-26 クインテセンス バイオサイエンシーズ インコーポレーティッド 修飾リボヌクレアーゼ
WO2008010991A2 (en) 2006-07-17 2008-01-24 Quintessence Biosciences, Inc. Methods and compositions for the treatment of cancer
RU2009136424A (ru) * 2007-03-02 2011-04-10 СЕНТ СИМЕОН ЭлДиЭй (US) Композиция и способ лечения папилломавируса и саркоидов лошадей
WO2009036000A2 (en) * 2007-09-11 2009-03-19 University Of Maryland, Baltimore Methods of treating a microbial infection by modulating rnase-l expression and/or activity
EP2205271B1 (en) * 2007-10-08 2014-05-21 Quintessence Biosciences, Inc. Compositions and methods for ribonuclease-based therapies
JP2012504423A (ja) 2008-10-01 2012-02-23 クインテッセンス バイオサイエンシズ，インコーポレーテッド 治療用リボヌクレアーゼ
WO2010099182A1 (en) * 2009-02-25 2010-09-02 Board Of Regents Of The University Of Nebraska Activated creatinine and precursors as antibacterial agents, compositions and products containing such agents and uses thereof
NZ600269A (en) 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
PL2457576T3 (pl) 2010-11-29 2021-04-06 Eurochit Danuta Kruszewska Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji
RU2548803C2 (ru) * 2011-11-28 2015-04-20 Общество с ограниченной ответственностью " Фарматренд" ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ ГЛАЗНЫХ ИНФЕКЦИЙ P. Aeruginosa, СОДЕРЖАЩАЯ РЕКОМБИНАНТНЫЙ ЛИЗОЦИМ
RU2509801C2 (ru) * 2012-03-22 2014-03-20 Борис Михайлович Куриненко СПОСОБ ИСПОЛЬЗОВАНИЯ РИБОНУКЛЕАЗЫ Bacillus intermedius
WO2013180585A1 (en) 2012-05-29 2013-12-05 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
EP2674162A1 (en) 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
RU2504397C1 (ru) * 2012-10-25 2014-01-20 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая фермент рибонуклеазу и глицирризиновую кислоту или ее соли: глицирризинат аммония, или дикалия, или тринатрия
WO2014152678A1 (en) 2013-03-15 2014-09-25 University Of Massachusetts Compositions and methods for delivering agents to the central nervous system
US9573980B2 (en) 2013-03-15 2017-02-21 Spogen Biotech Inc. Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots
CN106029089B (zh) * 2014-02-21 2020-12-29 丘比株式会社 诺如病毒灭活剂及其制造方法
EP3175713A4 (en) * 2014-07-31 2018-04-18 Kewpie Corporation Water-containing fluid composition, method for producing same, processed lysozyme and/or salt thereof, and method for producing same
BR122023020774A2 (pt) 2014-09-17 2024-01-23 Spogen Biotech Inc. Bactéria recombinante formadora de esporos, sua formulação, e semente de planta revestida com as mesmas
LV15071B (lv) * 2015-07-14 2016-02-20 Rīgas Stradiņa Universitāte Kompozīcija subklīniska mastīta ārstēšanai govīm
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
KR102470362B1 (ko) 2016-12-28 2022-11-25 디아이씨 가부시끼가이샤 분산체 및 그것을 사용한 잉크젯용 잉크 조성물, 광변환층, 및 액정 표시 소자
EP3684168A4 (en) 2017-09-20 2021-10-27 Spogen Biotech Inc. FUSION PROTEINS, RECOMBINANT BACTERIA AND EXOSPORIUM FRAGMENTS FOR PLANT HEALTH
EP4003300A4 (en) * 2019-07-26 2023-06-28 Infinant Health, Inc Nutritive compositions with bioactive proteins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1268M (fr) * 1961-06-29 1962-04-24 Puiseux Médicament antimitotique et antiviral.
FR4020M (hu) * 1965-01-29 1966-03-21
DE1517751C3 (de) * 1965-07-08 1975-02-27 Eisai Co., Ltd., Tokio Verfahren zum Verhindern der Bildung von flockigen Lysozym- und/oder Lysozymsalzniederschlägen in wässrigen Lösungen, die Lysozym und/oder Lysozymsalze enthalten
DE1545644A1 (de) * 1965-12-06 1969-08-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen quaternaeren Scopolammoniumsalzen
GB1110504A (en) * 1966-03-18 1968-04-18 Prodotti Antibiotici Spa Pharmaceutical compositions
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
EP0187705A3 (en) * 1985-01-08 1988-05-11 Norwich Eaton Pharmaceuticals, Inc. Imidazo(4,5-f)quinolines useful as immunomodulating agents
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
RU2092183C1 (ru) * 1988-05-26 1997-10-10 Ника Хелт Продактс Лимитед (Лихтенштейн) Антивирусный или антибактериальный состав и способ его употребления

Also Published As

Publication number Publication date
LV10054A (lv) 1994-05-10
PH26284A (en) 1992-04-10
CA1335425C (en) 1995-05-02
DK16890A (da) 1990-01-22
YU109289A (en) 1991-08-31
EP0380484A1 (en) 1990-08-08
US5466449A (en) 1995-11-14
MW390A1 (en) 1990-11-14
ZA893382B (en) 1991-01-30
HU883981D0 (en) 1990-12-28
AU1940888A (en) 1989-12-12
US5200182A (en) 1993-04-06
BG91270A (bg) 1993-12-24
DK16890D0 (da) 1990-01-22
DK173078B1 (da) 1999-12-20
BG60544B1 (en) 1995-08-28
FI900412A0 (fi) 1990-01-25
JPH0649659B2 (ja) 1994-06-29
MA21560A1 (fr) 1989-12-31
RU2092183C1 (ru) 1997-10-10
WO1989011294A1 (en) 1989-11-30
HK42394A (en) 1994-05-13
EP0380484B1 (en) 1993-08-18
OA09785A (en) 1994-04-15
JPH03504121A (ja) 1991-09-12
ES2011577A6 (es) 1990-01-16
ATE93143T1 (de) 1993-09-15
CS277030B6 (en) 1992-11-18
AU624331B2 (en) 1992-06-11
CS318089A3 (en) 1992-05-13
IL90092A (en) 1995-03-30
US6099835A (en) 2000-08-08
HUT54060A (en) 1991-01-28
HU204710B (en) 1992-02-28

Similar Documents

Publication Publication Date Title
US6099835A (en) Method of using antiviral composition
EP0090837A1 (en) Method and composition for treating a patient suffering from interferonsusceptible disorder
CN109985069B (zh) 益生菌组合物及其用途
Al-Nakib et al. Intranasal chalcone, Ro 09–0410, as prophylaxis against rhinovirus infection in human volunteers
US6132715A (en) Method of inhibiting biosynthesis of tumor necrosis factor
US5342612A (en) Compositions for the treatment of mammalian diseases
US3721733A (en) Anti-microbial compositions containing histaminase
KR930004599B1 (ko) 항바이러스성 또는 항균성 조성물
Ochs Treatment of external otitis; a simple and effective technic
DE3883392T2 (de) Verwendung eines Lysozymdimeren und/oder Ribonucleasedimeren zur Herstellung eines antiviralen oder antibakteriellen Arzneimittels.
RO110037B1 (ro) Compoziții antivirale sau antibacteriene și metodă de tratare a infecțiilor, cu acestea
JOHNSON Dermatologic evaluation of yeast, tyrothricin, chlorophyll and nitrofurazone
Powell, SJ & MacLeod Ambilhar, a nitrothiazole derivative, in urinary tract bilharzia
Feo et al. Evaluation of tritheon (aminitrozole) in male trichomoniasis
MXPA97005246A (en) New applications of dimero de lisoz
MXPA97001730A (es) Vacuna enteral para infecciones vaginales